Search research articles
Contact Us
Filters
Showing results (1-10 of 335) with videos related to
Page
of 34
Sort By:
Medecine Sciences : M/S
|
November 1, 2003
[Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research]
Jean-Paul Moatti, Bruno Spire
Annual Review of Pharmacology and Toxicology
|
July 31, 2025
Community Aspects of HIV Biomedical Prevention
Bruno Spire, Marion di Ciaccio
Lancet (London, England)
|
August 12, 2008
Harm reduction and control of HIV in IDUs in France
M Patrizia Carrieri, Bruno Spire
AIDS Care
|
May 2, 2008
HIV/AIDS: a long-term research agenda for social sciences
Jean-Paul Moatti, Bruno Spire
AIDS (London, England)
|
April 26, 2007
'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations
Maria-Patrizia Carrieri, Bruno Spire
Lancet (London, England)
|
July 24, 2018
Tackling global health inequities in the HIV response
Keletso Makofane, Bruno Spire, Phumi Mtetwa
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
February 15, 2024
Fabian Docagne, Catherine Barthélémy, Bruno Spire
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Choice of therapeutic strategies in the context of HIV infection: key role of patient-reported outcomes
Fabienne Marcellin, Maria Patrizia Carrieri, Bruno Spire
AIDS (London, England)
|
August 24, 2004
Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south
Jean Paul Moatti, Bruno Spire, Michel Kazatchkine
Journal of the International AIDS Society
|
November 19, 2008
HIV prevention: What have we learned from community experiences in concentrated epidemics?
Bruno Spire, Isabelle de Zoysa, Hakima Himmich
Page
of 34
Search research articles
Search
Showing results (1-10 of 335) with videos related to
Sort By:
Page
of 34
Medecine Sciences : M/S
|
November 1, 2003
[Economic and socio-behavioural issues related to highly active antiretroviral therapies for HIV infection: the contribution of social science research]
Jean-Paul Moatti, Bruno Spire
Annual Review of Pharmacology and Toxicology
|
July 31, 2025
Community Aspects of HIV Biomedical Prevention
Bruno Spire, Marion di Ciaccio
Lancet (London, England)
|
August 12, 2008
Harm reduction and control of HIV in IDUs in France
M Patrizia Carrieri, Bruno Spire
AIDS Care
|
May 2, 2008
HIV/AIDS: a long-term research agenda for social sciences
Jean-Paul Moatti, Bruno Spire
AIDS (London, England)
|
April 26, 2007
'Forced treatment interruptions' and risk of HIV resistance in countries adopting law enforcement against marginalized populations
Maria-Patrizia Carrieri, Bruno Spire
Lancet (London, England)
|
July 24, 2018
Tackling global health inequities in the HIV response
Keletso Makofane, Bruno Spire, Phumi Mtetwa
Sante Publique (Vandoeuvre-Les-Nancy, France)
|
February 15, 2024
Fabian Docagne, Catherine Barthélémy, Bruno Spire
Expert Review of Anti-Infective Therapy
|
April 20, 2012
Choice of therapeutic strategies in the context of HIV infection: key role of patient-reported outcomes
Fabienne Marcellin, Maria Patrizia Carrieri, Bruno Spire
AIDS (London, England)
|
August 24, 2004
Drug resistance and adherence to HIV/AIDS antiretroviral treatment: against a double standard between the north and the south
Jean Paul Moatti, Bruno Spire, Michel Kazatchkine
Journal of the International AIDS Society
|
November 19, 2008
HIV prevention: What have we learned from community experiences in concentrated epidemics?
Bruno Spire, Isabelle de Zoysa, Hakima Himmich
Page
of 34